Claims
- 1. A liquid crystal shutter operating in the normal mode comprising a pair of mutually spaced substrates upon which are provided respective opposed alignment surfaces which are spaced apart, and a layer of liquid crystal composition filling the space between the alignment surfaces wherein the liquid crystal composition includes a host material comprising (a) two or more phenylpyrimidinyl compounds of the general formula (I): wherein X1 and X2 are independently selected from the group consisting of substituted or unsubstituted, straight or branched chain (C1-C12)alkyl, substituted or unsubstituted, straight or branched chain (C1-C12)alkenyl and substituted or unsubstituted, straight or branched chain (C1-C12) alkoxy, and (b) at least one fluoroterphenyl compound of the formula (II) or (III): wherein Y1 and Y2 are independently selected from the group consisting of substituted or unsubstituted, straight or branched chain (C1-C12) alkyl, substituted or unsubstituted, straight or branched chain (C1-C12) alkenyl and substituted or unsubstituted, straight or branched chain (C1-C12) alkoxy, and further includes at least one chiral dopant.
- 2. A shutter according to claim 1, wherein in the host material of the liquid crystal composition one or more of the phenyl rings of the fluoroterphenyl compound is/are replaced by a pyrimidine, a dioxane, a pyridine or a cyclohexane ring.
- 3. A shutter as claimed in claim 1, wherein X1, X2, Y1 and Y2 are independently selected from substituted or unsubstituted (C5-C10) alkyl, substituted or unsubstituted (C5-C10) alkenyl and substituted or unsubstituted (C5-C10) alkoxy.
- 4. A shutter as claimed in claim 1 wherein X1 and X2 are independently selected from substituted or unsubstituted (C7-C9) alkyl, substituted or unsubstituted (C7-C9) alkenyl and substituted or unsubstituted (C7-C9) alkoxy.
- 5. A shutter as claimed in claim 1 wherein Y1 and Y2, are independently selected from substituted or unsubstituted (C5-C8) alkyl, substituted or unsubstituted (C5-C8) alkenyl and substituted or unsubstituted (C5-C8) alkoxy.
- 6. A shutter as claimed in claim 1 wherein, in X1, X2, Y1 and Y2, the alkyl groups are linear.
- 7. A shutter as claimed in claim 1 wherein the amount of the fluoroterphenyl compound is in the range of 30-60% by weight of the total amount of the phenylpyrimidinyl and fluoroterphenyl compounds.
- 8. A liquid crystal shutter operating in the normal mode comprising a pair of mutually spaced substrates upon which are provided respective opposed alignment surfaces which are spaced apart, and a layer of liquid crystal composition filling the space between the alignment surfaces, wherein the liquid crystal composition includes(1) a host material comprising (a) two or more phenylpyrimidinyl compounds of the general formula (I): wherein X1 and X2 are independently selected from the group consisting of substituted or unsubstituted, straight or branched chain (C1-C12)alkyl, substituted or unsubstituted, straight or branched chain (C1-C12)alkenyl and substituted or unsubstituted, straight or branched chain (C1-C12) alkoxy, and (b) at least one fluoroterphenyl compound of the formula (II) or (III): wherein Y1 and Y2 are independently selected from the group consisting of substituted or unsubstituted, straight or branched chain (C1-C12) alkyl, substituted or unsubstituted, straight or branched chain (C1-C12) alkenyl and substituted or unsubstituted, straight or branched chain (C1-C12) alkoxy, and (2) at least one chiral dopant is present in an amount of about 1 to 15 wt % based on the total weight of the liquid crystal composition.
- 9. A shutter as claimed in claim 8 herein said at least one chiral dopant is present in an amount of 5 to 15 wt % based on the total weight of the liquid crystal composition.
- 10. A method of increasing the temperature at which the transition from the smectic A phase to the smectic C phase occurs in a liquid crystal shutter operating in the normal mode comprising a pair of mutually spaced substrates upon which are provided respective opposed alignment surfaces which are spaced apart, and a layer of liquid crystal composition filling the space between the alignment surfaces comprising employing a liquid crystal composition which includes a host material comprising (a) two or more phenylpyrimidinyl compounds of the general formula (I): wherein X1 and X2 are independently selected from the group consisting of substituted or unsubstituted, straight or branched chain (C1-C12)alkyl, substituted or unsubstituted, straight or branched chain (C1-C12)alkenyl and substituted or unsubstituted, straight or branched chain (C1-C12) alkoxy, and (b) at least one fluoroterphenyl compound of the formula (II) or (III): wherein Y1 and Y2 are independently selected from the group consisting of substituted or unsubstituted, straight or branched chain (C1-C12) alkyl, substituted or unsubstituted, straight or branched chain (C1-C12) alkenyl and substituted or unsubstituted, straight or branched chain (C1-C12) alkoxy, and further includes at least one chiral dopant.
- 11. A method according to claim 10 wherein in the host material of the liquid crystal composition one or more of the phenyl rings of the fluoroterphenyl compound is/are replaced by a pyrimidine, a dioxane, a pyridine or a cyclohexane ring.
- 12. A method as claimed in claim 10 wherein X1, X2, Y1 and Y2 are independently selected from substituted or unsubstituted (C5-C10) alkyl, substituted or unsubstituted (C5-C10) alkenyl and substituted or unsubstituted (C5-C10) alkoxy.
- 13. A method as claimed in claim 10 wherein X1 and X2 are independently selected from substituted or unsubstituted (C7-C9) alkyl, substituted or unsubstituted (C7-C9) alkenyl and substituted or unsubstituted (C7-C9) alkoxy.
- 14. A method as claimed in claim 10 wherein Y1, and Y2, are independently selected from substituted or unsubstituted (C5-C8) alkyl, substituted or unsubstituted (C5-C8) alkenyl and substituted or unsubstituted (C5-C8) alkoxy.
- 15. A method as claimed in claim 10 wherein, in X1, X2, Y1 and Y2, the alkyl groups are linear.
- 16. A method as claimed in claim 10 wherein the amount of the fluoroterphenyl compound is in the range of 30-60% by weight of the total amount of the phenylpyrimidinyl and fluoroterphenyl compounds.
- 17. A method as claimed in claim 10 wherein said at least one chiral dopant is present in an amount of about 1 to 15 wt % based on the total weight of the liquid crystal composition.
- 18. A method as claimed in claim 17 wherein said at least one chiral dopant is present in an amount of 5 to 15 wt % based on the total weight of the liquid crystal composition.
Priority Claims (1)
Number |
Date |
Country |
Kind |
9723949 |
Nov 1997 |
GB |
|
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national phase of international application PCT/GB98/03361, filed Nov. 10, 1998 which designated the U.S.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/GB98/03361 |
|
WO |
00 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO99/25789 |
5/27/1999 |
WO |
A |
US Referenced Citations (4)
Number |
Name |
Date |
Kind |
5507975 |
Koden et al. |
Apr 1996 |
A |
5820786 |
Sage et al. |
Oct 1998 |
A |
6251301 |
Sage et al. |
Jun 2001 |
B1 |
6280653 |
Jones et al. |
Aug 2001 |
B1 |
Foreign Referenced Citations (5)
Number |
Date |
Country |
0 360 043 |
Mar 1990 |
EP |
0 414 230 |
Feb 1991 |
EP |
0 414 230 |
Feb 1991 |
EP |
8902425 |
Mar 1989 |
WO |
9516760 |
Jun 1995 |
WO |